EDIT
Price
$2.65
Change
-$0.03 (-1.12%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
240.09M
73 days until earnings call
OSRH
Price
$0.74
Change
-$0.14 (-15.91%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
15.98M
Interact to see
Advertisement

EDIT vs OSRH

Header iconEDIT vs OSRH Comparison
Open Charts EDIT vs OSRHBanner chart's image
Editas Medicine
Price$2.65
Change-$0.03 (-1.12%)
Volume$3.77K
Capitalization240.09M
OSR Holdings
Price$0.74
Change-$0.14 (-15.91%)
Volume$400
Capitalization15.98M
EDIT vs OSRH Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSRH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. OSRH commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Buy and OSRH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (EDIT: $2.65 vs. OSRH: $0.88)
Brand notoriety: EDIT and OSRH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 32% vs. OSRH: 20%
Market capitalization -- EDIT: $240.09M vs. OSRH: $15.98M
EDIT [@Biotechnology] is valued at $240.09M. OSRH’s [@Biotechnology] market capitalization is $15.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileOSRH’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • OSRH’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than OSRH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while OSRH’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 5 bearish.
  • OSRH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both EDIT and OSRH are a bad buy in the short-term.

Price Growth

EDIT (@Biotechnology) experienced а -2.93% price change this week, while OSRH (@Biotechnology) price change was +75.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($240M) has a higher market cap than OSRH($16M). EDIT YTD gains are higher at: 108.661 vs. OSRH (-92.356). OSRH has higher annual earnings (EBITDA): -12.05M vs. EDIT (-227.72M). EDIT has more cash in the bank: 179M vs. OSRH (1.58M). OSRH has less debt than EDIT: OSRH (4.3M) vs EDIT (21.1M). EDIT has higher revenues than OSRH: EDIT (38.9M) vs OSRH (105K).
EDITOSRHEDIT / OSRH
Capitalization240M16M1,500%
EBITDA-227.72M-12.05M1,890%
Gain YTD108.661-92.356-118%
P/E RatioN/AN/A-
Revenue38.9M105K37,048%
Total Cash179M1.58M11,301%
Total Debt21.1M4.3M491%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITOSRH
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
13%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
13%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSRH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTSF28.65N/A
N/A
Lectra Systems
VLPNF21.93N/A
N/A
Voestalpine AG
ELRRF0.81-0.01
-1.22%
Eloro Resources Ltd.
DGDCF0.11N/A
-1.75%
Dynasty Gold Corp.
SCMWY71.60-2.15
-2.92%
Swisscom AG

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
-9.90%
MIST - OSRH
29%
Poorly correlated
+4.73%
EDSA - OSRH
23%
Poorly correlated
-1.23%
EPIX - OSRH
23%
Poorly correlated
-6.65%
EDIT - OSRH
21%
Poorly correlated
-2.20%
VERA - OSRH
21%
Poorly correlated
-2.31%
More